Organigram Global Inc. Common Shares (OGI) is a publicly traded Healthcare sector company. As of May 21, 2026, OGI trades at $1.07 with a market cap of $148.52M and a P/E ratio of 0.00. OGI moved +3.37% today. Year to date, OGI is -36.69%; over the trailing twelve months it is -20.74%. Its 52-week range spans $0.85 to $2.24. Analyst consensus is strong buy with an average price target of $2.50. Rallies surfaces OGI's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Organigram’s Q1 Revenue Drops 10% to CA$30 Million, Eyes German Exports: Organigram’s Q1 cannabis revenue fell 10% to CA$30 million, driving a CA$5 million net loss and compressing gross margin by 300 basis points. The company signed its first German distribution deal, targeting initial exports in Q3 2026.
| Metric | Value |
|---|---|
| Price | $1.07 |
| Market Cap | $148.52M |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
| Dividend Yield | 0.00% |
| 52-Week High | $2.24 |
| 52-Week Low | $0.85 |
| Volume | 0 |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $0 |
| Gross Margin | 0.00% |
4 analysts cover OGI: 0 strong buy, 4 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $2.50.